2020, Volume 66, Issue 4  |
| REVIEWS |
| 279-293 |
Lokhov P.G., Balashova E.E., Trifonova O.P., Maslov D.L., Archakov A.I.
Ten years of the Russian metabolomics: history of development and achievements
|
   |
| EXPERIMENTAL STUDIES |
| 294-316 |
Novikova S.E., Farafonova T.E., Tikhonova O.V., Shushkova N.A., Pyatnitsky M.A., Zgoda V.G., Ponomarenko E.A., Lisitsa A.V., Grigoryev A.I., Tutelyan V.A., Archakov A.I.
Mass-spectrometric MRM analysis of FDA-verified proteins in the blood plasma of healthy volunteers
|
 |
| 317-325 |
Eliferov V.A., Zhvansky E.S., Sorokin A.A., Shurkhay V.A., Bormotov D.S., Pekov S.I., Nikitin P.V., Ryzhova M.V., Kulikov E.E., Potapov A.A., Nikolaev E.N., Popov I.A.
The role of lipids in the classification of astrocytoma and glioblastoma using MS tumor profiling
|
|
| 326-331 |
Lizunov A.V., Okunevich I.V., Lebedev A.A., Bychkov E.R., Piotrovskiy L.B., Shabanov P.D.
Molecular mechanisms of the cytoprotector cramizol effect in the experimental dyslipidemia model
|
 |
| 332-338 |
Neganova M.E., Aleksandrova Yu.R., Pukhov S.A., Klochkov S.G., Osipov V.N.
Mechanisms of cytotoxic action of a series of directionally synthesized heterocyclic hydroxamic acids
|
|
| 339-344 |
Novikov V.E., Levchenkova O.S.
Erythropoietin and vascular endothelial growth factor level in normoxia and in cerebral ischemia under pharmacological and hypoxic preconditioning
|
|
| CLINICAL AND DIAGNOSTIC RESEARCH |
| 345-352 |
Semochkina Yu.P., Moskaleva E.Yu., Malashenkova I.K., Krynskiy S.A., Hailov N.A., Ogurtsov D.P., Ponomareva E.V., Gavrilova S.I.
Effectiveness of the DNA double-strand breaks repair system in lymphocytes of patients with cognitive impairments and healthy volunteers
|
|